STUDY FUNDING AGREEMENTStudy Funding Agreement • August 11th, 2003 • Hollis Eden Pharmaceuticals Inc /De/ • Pharmaceutical preparations • Delaware
THIS STUDY FUNDING AGREEMENT, dated as of June 17, 2003, is made by and between Hollis-Eden Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware, having offices located at 4435 Eastgate Mall, Suite 400, San Diego, CA 92121 (“H-E”), and Cystic Fibrosis Foundation Therapeutics, Inc., a not for profit corporation organized and existing under the laws of the State of Delaware, having offices located at 6931 Arlington Road, Bethesda, Maryland 20814 (“CFFT”) with respect to the Study Protocol and involving the Compound, both as defined below.
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • August 11th, 2003 • Hollis Eden Pharmaceuticals Inc /De/ • Pharmaceutical preparations
Effective March 11, 2003 (the “Effective Date”), Hollis-Eden Pharmaceuticals, Inc., a Delaware corporation (the “Company”), William H. Tilley (“Tilley”) and JacMar/Viking, L.L.C., a Delaware limited liability company (“Consultant”), agree as follows:
